(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MEDAMIGO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

MEDAMIGO

ST13

US500000079256760

Class

9, 42

Filing

79256760

Registration

5899820

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

06/16/2026

Trademark type

Word

Nice classes

9, 42

Filing date

01/16/2019

Registration date

11/05/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/22/2026

Last transaction

06/16/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

BE

Examiner

SEVERSON, JUSTIN

Law office

M20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

AARDEX GROUP, Société anonyme

Representatives

Christina M. Licursi, Esq. Wolf Greenfield & Sacks, P.C.

Technical classification

Nice Classes

Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Scientific apparatus and instrumentselectronic analyzers and physical and chemical laboratory apparatus and instruments used for drug detection and the analysis of body fluids for scientific purposes; apparatus for information recording and processing; measuringcontrol and inspection apparatus and instrumentsfor scientific usegauges for measuring drug concentration levels for scientific purposes; blank digital recording storage media; data processing equipmentdata processors; apparatus for recordingtransmittingprocessing and reproducing data; apparatus for processingtransmission and storage of database informationcomputers; apparatus for recording time and the datecomputers; software applications for use on mobile devices for use in data processing and database management in the fields of pharmaceuticals and biotechnology; downloadable applications for mobile devices for use in data processing and database management in the fields of pharmaceuticals and biotechnology; computer memory devices for use with data processing apparatus; LCD display screens; electronic data recorders; software for use in data processing and database management in the fields of pharmaceuticals and biotechnology; compiling software; database management software; downloadable electronic publicationsmanuals featuring pharmaceutical and biotechnology content recorded on computer media; data processing systemsdata processors; downloadable cloud computing software for use in data processing and database management in the fields of pharmaceuticals and biotechnology

Class 42

Scientific and technological servicesas well as research and design relating theretoresearch and development of technology in the fields of pharmaceuticals and biotechnology; design and development of software; scientific assessmentsestimatesresearch and reportingconducting scientific research in the fields of pharmaceuticals and biotechnology; engineering services and design and advisory services with respect to information technologies concerning the securing of computer data and personal and financial information and concerning the detection of unauthorized access to data and information; scientific research services in the medical field; designdevelopmentrental and programming of operating software for accessing as well as using a cloud computing network; digital compression of computer data; design of data processing apparatus; computer database design; designdevelopmentmaintenance and updating of data processing software; design and development of medical technologies; development of data processing software; quality evaluation of pharmaceutical products; pharmaceutical research and development services

Publications

History of USPTO decisions and trademark events.

29 publications found

C71T

CANCELLED SECTION 71

05/22/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

11/05/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/27/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

03/05/2020

FIMP

FINAL DISPOSITION PROCESSED

03/05/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/05/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

11/05/2019

GPNX

NOTIFICATION PROCESSED BY IB

08/23/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/20/2019

PUBO

PUBLISHED FOR OPPOSITION

08/20/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/07/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/07/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/31/2019

ALIE

ASSIGNED TO LIE

07/12/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/03/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/03/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/01/2019

RFNT

REFUSAL PROCESSED BY IB

06/08/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/06/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/05/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/05/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/20/2019

RFRR

REFUSAL PROCESSED BY MPU

05/20/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/27/2019

MAFR

APPLICATION FILING RECEIPT MAILED

04/27/2019

CNRT

NON-FINAL ACTION WRITTEN

04/26/2019

DOCK

ASSIGNED TO EXAMINER

04/23/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/23/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

04/18/2019

Continuous trademark protection

Get notified about every new filing that threatens MEDAMIGO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.